Gencell Ltd (TLV:GNCL)
Israel · Delayed Price · Currency is ILS · Price in ILA 24.00
0.00 (0.00%)
Jul 31, 2025, 5:24 PM IDT
SpringWorks Therapeutics Revenue
In the year 2024, Gencell had annual revenue of $9.55M USD with 96.32% growth. Gencell had revenue of $9.27M in the half year ending December 31, 2024, with 50.31% growth.
Revenue
$9.55M
Revenue Growth
+96.32%
P/S Ratio
0.77
Revenue / Employee
$90.94K
Employees
105
Market Cap
26.73M
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.55M | 4.69M | 96.32% |
| Dec 31, 2023 | 4.86M | -2.54M | -34.30% |
| Dec 31, 2022 | 7.40M | 1.86M | 33.58% |
| Dec 31, 2021 | 5.54M | 5.22M | 1,610.49% |
| Dec 31, 2020 | 324.00K | -859.00K | -72.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Elbit Systems | 26.70B |
| NextVision Stabilized Systems | 461.24M |
| Shapir Engineering and Industry | 5.33B |
| Shikun & Binui | 8.89B |
| Electra | 12.75B |
| El Al Israel Airlines | 12.91B |
| Bet Shemesh Engines Holdings (1997) | 1.00B |
| Lapidoth Capital | 7.89B |